All-DOC Day, an annual event sponsored by the Dartmouth Outing Club will be hosted this Thursday, May 19th from 3-6 p.m. outside of Mass Row. The event will include a free barbecue and demonstrations of various activities. Planned activities include "kayaking" down the steps of Massachusetts Hall, performances of the Salty Dog Rag and bicycle repair demonstrations. Members of the forestry team and Dartmouth Mountaineering Club will also showcase at the event.
Ada Graham '08, president of the DOC, said she hopes the event will garner new interest for the DOC, especially among those who have not been involved with the organization since their freshman trips. A canopy will be used in the case of rain.
Thomas Ulich '75 was appointed last week to serve as the Executive Vice President of Research and Development of ConjuChem Inc. ConjuChem is a biomedical company based in Toronto that creates medicines from therapeutic peptides. It also develops technologies to treat chronic illnesses such as diabetes, human growth deficiencies and HIV/AIDS.
After graduating from Dartmouth, Ulich received his M.D., served as a resident at the University of California at Los Angeles and then pursued his post-doctoral fellowship at the Scripps Research Foundation in La Jolla, California. To join ConjuChem, he will leave his post as a professor of pathology at Wayne State University where he was also the co-director of the Pathosphysiology Curriculum.
Columbia Business School announced last week that it will receive a total of $45 million in gifts from three well-known alumni. Finance legends Russell Carson and Henry Kravis plan to donate $10 million each, and Arthur Samberg will round out the generous gift with an additional $25 million. The money will be used to improve curriculum and attract new faculty, according to Glenn Hubbard, the dean of the Business School at Columbia. "The present challenge for the top business schools, as I see it, is to inspire our researchers to be in close contact with business leaders and to answer practical questions for the rigorous and vigorous scrutiny of real-world application," Hubbard said.
